Cargando…

Reversible inhibition of the oxidase-like activity of Fe single-atom nanozymes for drug detection

Mechanism research of nanozymes has always been of great interest since their emergence as outstanding mimics of friable natural enzymes. An important but rarely mentioned issue in mechanism research of nanozymology is the inhibitory effect of nanozymes. And conventional nanozymes with various activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Weiwei, Huang, Liang, Zhu, Xinyang, Chen, Jinxing, Chao, Daiyong, Li, Minghua, Wu, Shuangli, Dong, Shaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020197/
https://www.ncbi.nlm.nih.gov/pubmed/35656135
http://dx.doi.org/10.1039/d2sc00212d
_version_ 1784689484323880960
author Wu, Weiwei
Huang, Liang
Zhu, Xinyang
Chen, Jinxing
Chao, Daiyong
Li, Minghua
Wu, Shuangli
Dong, Shaojun
author_facet Wu, Weiwei
Huang, Liang
Zhu, Xinyang
Chen, Jinxing
Chao, Daiyong
Li, Minghua
Wu, Shuangli
Dong, Shaojun
author_sort Wu, Weiwei
collection PubMed
description Mechanism research of nanozymes has always been of great interest since their emergence as outstanding mimics of friable natural enzymes. An important but rarely mentioned issue in mechanism research of nanozymology is the inhibitory effect of nanozymes. And conventional nanozymes with various active sites hinder the mechanism research, while single-atom Fe–N–C nanozymes with similar active sites to natural enzymes exhibit structural advantages. Herein, we synthesized Fe single-atom nanozymes (Fe-SANs) with ultrahigh oxidase-like activity and found that a common analgesic-antipyretic drug 4-acetamidophenol (AMP) had inhibitory effects for the oxidase-like activity of Fe-SANs. We investigated the inhibitory effects in detail and demonstrated that the inhibition type was reversible mixed-inhibition with inhibition constants (K(i) and [Image: see text]) of 0.431 mM and 0.279 mM, respectively. Furthermore, we put forward a colorimetric method for AMP detection based on nanozyme inhibition. The research on the inhibitory effects of small molecules on nanozymes expands the scope of analysis based on nanozymes and the inhibition mechanism study may offer some insight into investigating the interaction between nanozymes and inhibitors.
format Online
Article
Text
id pubmed-9020197
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-90201972022-06-01 Reversible inhibition of the oxidase-like activity of Fe single-atom nanozymes for drug detection Wu, Weiwei Huang, Liang Zhu, Xinyang Chen, Jinxing Chao, Daiyong Li, Minghua Wu, Shuangli Dong, Shaojun Chem Sci Chemistry Mechanism research of nanozymes has always been of great interest since their emergence as outstanding mimics of friable natural enzymes. An important but rarely mentioned issue in mechanism research of nanozymology is the inhibitory effect of nanozymes. And conventional nanozymes with various active sites hinder the mechanism research, while single-atom Fe–N–C nanozymes with similar active sites to natural enzymes exhibit structural advantages. Herein, we synthesized Fe single-atom nanozymes (Fe-SANs) with ultrahigh oxidase-like activity and found that a common analgesic-antipyretic drug 4-acetamidophenol (AMP) had inhibitory effects for the oxidase-like activity of Fe-SANs. We investigated the inhibitory effects in detail and demonstrated that the inhibition type was reversible mixed-inhibition with inhibition constants (K(i) and [Image: see text]) of 0.431 mM and 0.279 mM, respectively. Furthermore, we put forward a colorimetric method for AMP detection based on nanozyme inhibition. The research on the inhibitory effects of small molecules on nanozymes expands the scope of analysis based on nanozymes and the inhibition mechanism study may offer some insight into investigating the interaction between nanozymes and inhibitors. The Royal Society of Chemistry 2022-03-24 /pmc/articles/PMC9020197/ /pubmed/35656135 http://dx.doi.org/10.1039/d2sc00212d Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Chemistry
Wu, Weiwei
Huang, Liang
Zhu, Xinyang
Chen, Jinxing
Chao, Daiyong
Li, Minghua
Wu, Shuangli
Dong, Shaojun
Reversible inhibition of the oxidase-like activity of Fe single-atom nanozymes for drug detection
title Reversible inhibition of the oxidase-like activity of Fe single-atom nanozymes for drug detection
title_full Reversible inhibition of the oxidase-like activity of Fe single-atom nanozymes for drug detection
title_fullStr Reversible inhibition of the oxidase-like activity of Fe single-atom nanozymes for drug detection
title_full_unstemmed Reversible inhibition of the oxidase-like activity of Fe single-atom nanozymes for drug detection
title_short Reversible inhibition of the oxidase-like activity of Fe single-atom nanozymes for drug detection
title_sort reversible inhibition of the oxidase-like activity of fe single-atom nanozymes for drug detection
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020197/
https://www.ncbi.nlm.nih.gov/pubmed/35656135
http://dx.doi.org/10.1039/d2sc00212d
work_keys_str_mv AT wuweiwei reversibleinhibitionoftheoxidaselikeactivityoffesingleatomnanozymesfordrugdetection
AT huangliang reversibleinhibitionoftheoxidaselikeactivityoffesingleatomnanozymesfordrugdetection
AT zhuxinyang reversibleinhibitionoftheoxidaselikeactivityoffesingleatomnanozymesfordrugdetection
AT chenjinxing reversibleinhibitionoftheoxidaselikeactivityoffesingleatomnanozymesfordrugdetection
AT chaodaiyong reversibleinhibitionoftheoxidaselikeactivityoffesingleatomnanozymesfordrugdetection
AT liminghua reversibleinhibitionoftheoxidaselikeactivityoffesingleatomnanozymesfordrugdetection
AT wushuangli reversibleinhibitionoftheoxidaselikeactivityoffesingleatomnanozymesfordrugdetection
AT dongshaojun reversibleinhibitionoftheoxidaselikeactivityoffesingleatomnanozymesfordrugdetection